The risk of cardiovascular events in patients with resistant hypertension

被引：0
|
作者：
Yuan, Zhong [1 ]
Swerdel, Joel N. [2 ]
Ryan, Patrick B. [3 ]
Osokogu, Osemeke [4 ]
Saran, Sukhdev K. [1 ]
Haskell, Lloyd [1 ]
机构：
[1] Janssen R&D, Beerse, Belgium
[2] Janssen Pharmaceut Inc, Beerse, Belgium
[3] Johnson & Johnson, New Brunswick, NJ USA
[4] Janssen Global Med Safety, High Wycombe, Bucks, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
499
引用
收藏
页码：232 / 233
页数：2
相关论文
共 50 条
  • [21] Risk factors for cardiovascular and cerebrovascular events in patients with uremia and hypertension during maintenance hemodialysis
    Zhang, Xing
    Zhang, Wenjuan
    Wang, Fei
    Chu, Yang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (04): : 1228 - 1236
  • [22] Silent brain infarcts, peripheral vascular disease and the risk of cardiovascular events in patients with hypertension
    Jimenez-Balado, Joan
    Riba-Llena, Iolanda
    Nafria, Cristina
    Pizarro, Jesus
    Rodriguez-Luna, David
    Maisterra, Olga
    Ballve, Alejandro
    Mundet, Xavier
    Violan, Concepcion
    Ventura, Oriol
    Montaner, Joan
    Delgado, Pilar
    JOURNAL OF HYPERTENSION, 2022, 40 (08) : 1469 - 1477
  • [23] Nighttime Hypertension is a Risk Factor for Cardiovascular Events in Stage B Heart Failure Patients
    Komori, Takahiro
    Hoshide, Satoshi
    Kario, Kazuomi
    CIRCULATION, 2023, 148
  • [24] Framingham risk and major adverse cardiovascular events among patients with hypertension ineligible for SPRINT
    Petito, Lucia
    Huang, Xiaoning
    Jefferson, Celeena
    Vupputuri, Suma
    Lancki, Nicola
    Ahmad, Faraz
    Kazi, Dhruv
    Ndumele, Chiadi
    Allen, Norrina
    Persell, Stephen
    Shah, Nilay
    Lloyd-Jones, Donald
    Khan, Sadiya
    CIRCULATION, 2024, 150
  • [25] Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
    Eikelboom, JW
    Hirsh, J
    Weitz, JI
    Johnston, M
    Yi, Q
    Yusuf, S
    CIRCULATION, 2002, 105 (14) : 1650 - 1655
  • [26] Target blood pressure levels and the risk of major adverse cardiovascular events among patients with hypertension at low cardiovascular disease risk
    Jiao, Tianze
    Platt, Robert W.
    Douros, Antonios
    Filion, Kristian B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 350 - 350
  • [27] Exercise and Cardiovascular Risk in Patients With Hypertension
    Sharman, James E.
    La Gerche, Andre
    Coombes, Jeff S.
    AMERICAN JOURNAL OF HYPERTENSION, 2015, 28 (02) : 147 - 158
  • [28] No increased risk of cardiovascular events with dapagliflozin in elderly patients with type 2 diabetes mellitus, cardiovascular disease and hypertension
    Gause-Nilsson, I.
    Sonesson, C.
    Johansson, P. A.
    Johnsson, E.
    DIABETOLOGIA, 2015, 58 : S362 - S363
  • [29] No Increased Risk of Cardiovascular Events with Dapagliflozin in Elderly Patients with Type 2 Diabetes Mellitus, Cardiovascular Disease, and Hypertension
    Gause-Nilsson, Ingrid Ami
    Sonesson, Christian
    Johansson, Peter A.
    Sugg, Jennifer E.
    Johnsson, Eva
    DIABETES, 2015, 64 : A4 - A4
  • [30] Clinical Question: Can CPAP suppress cardiovascular events in resistant hypertension patients with obstructive sleep apnea?
    Shinobu Osanai
    Hypertension Research, 2023, 46 : 1606 - 1608
12345